DEVELOPMENT OF A PLATFORM FOR IDENTIFICATION OF MUTANOA AND PERSONALISED VACCINATION IN CANCER PATIENTS — PRCIVEX (Q2019366): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in es, and other parts: Adding Spanish translations) |
(Changed an Item: import item from Italy) |
||
| Property / location (string) | |||
ROMA | |||
| Property / location (string): ROMA / rank | |||
Normal rank | |||
| Property / location (string) | |||
NAPOLI | |||
| Property / location (string): NAPOLI / rank | |||
Normal rank | |||
Revision as of 08:48, 7 February 2022
Project Q2019366 in Italy
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | DEVELOPMENT OF A PLATFORM FOR IDENTIFICATION OF MUTANOA AND PERSONALISED VACCINATION IN CANCER PATIENTS — PRCIVEX |
Project Q2019366 in Italy |
Statements
986,675.87 Euro
0 references
1,329,656.71 Euro
0 references
74.21 percent
0 references
1 November 2016
0 references
31 December 2018
0 references
NOUSCOM SOCIETA' A RESPONSABILITA' LIMITATA
0 references
BIOTECNOLOGIE (Italian)
0 references
BIOTECHNOLOGY (English)
0 references
ROMA
0 references
NAPOLI
0 references
Identifiers
B88I17000390008
0 references